Warning letter
Sharp Drugs, Inc. dba Island Drug and Surgical: warning letter of Aug 2, 2019
FDA warning letter 588331 · Division of Pharmaceutical Quality Operations I
Key facts
| Reference number | 588331 |
|---|---|
| Company | Sharp Drugs, Inc. dba Island Drug and Surgical |
| Subject | Drug Product/Adulterated |
| Issue date | Aug 2, 2019 |
| Posted date | Sep 10, 2019 |
| Issuing office | Division of Pharmaceutical Quality Operations I |
| Product type | Drugs |
| Inspection city | Westhampton Beach |
| Inspection ZIP | 11978 |
| Inspection start date | Jul 10, 2018 |
| Letter on fda.gov | fda.gov |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: